Adamed to double production capacity with €100M Spain plant, PLN 700M Poland investment

Polish pharmaceutical firm Adamed plans to double production capacity by 2030, allocating over €100 million to its acquired Spanish plant and around PLN 700 million to Polish investments, including a new inhalable drug factory in Pabianice. The expansion signals a strategic push into European manufacturing, but details on funding and timeline remain unspecified.